The New Drug Research and Development Center focuses on innovative drug co development, mainly participating in early clinical trials and post market clinical application re research, aiming to accelerate the development and promotion of original new drugs, and solve unmet clinical needs.

We have a rich and highly competitive product pipeline, covering treatment areas such as autoimmune diseases, metabolic diseases, anti-tumor, anti-aging, cardiovascular and cerebrovascular diseases, and Parkinson's disease. We have developed AI+natural molecules and have reserved 851 natural plant derived monomeric compounds.